Wei Zhao, Pharm.D., Ph.D., Professor of clinical pharmacist and pharmacologist currently working as the chair of department of clinical pharmacy and director of institute of clinical pharmacology at Shandong University, deputy director of NMPA key laboratory for clinical research and evaluation of innovative drug at Qilu Hospital and directors of clinical trial centers at Shandong Provincial Qianfoshan Hospital and the Second Hospital of Shandong University, China. He leads a research group focused on clinical trial and personalized therapy.
Prof Zhao also works as a regulator scientist. He was nominated as a member and expert of the pediatric committee in the French National Agency of Medicine and Health Products Safety in 2015 and a member and expert of modeling & simulation working party and extrapolation working group in European Medicines Agency. He collaborates with the Chinese Center for Drug Evaluation to develop the national guidelines for drug development.
山东大学临床药理研究所所长、药学院临床药学系主任；山东大学第二医院药物临床试验机构副主任、研究型病房主任；山东省千佛山医院药物临床研究中心主任；创新药临床研究与评价国家药品监督管理局重点实验室常务副主任；山东省儿童药物临床评价与研发工程技术研究中心主任；山东省泰山学者特聘专家
国家药品监督管理局新药审评专家；欧盟药监局新药审评专家、建模与仿真委员会常务委员、创新方法委员会专家；法国药监局儿科药物评审委员会副主任；British Journal of Clinical Pharmacology执行主编；BMJ Pediatrics副主编；Frontiers in Pharmacology副主编, Frontiers in Pediatrics副主编；Journal of Clinical Pharmacology编委
赵维教授在创新药临床试验与特殊人群个体化治疗研究领域有丰富的临床和科研经验。在Clinical Pharmacology and Therapeutics, Clinical Pharmacokinetics, Journal of Antimicrobial Chemotherapy等杂志，发表SCI论文150余篇。获得欧盟第七框架、地平线2020，科技部重大新药创制专项、国家重点研发计划、国家自然科学基金等20余项课题资助；做为PI主持创新药早期临床试验100余项；做为第一完成人，获得教育部科技进步二等奖1项、山东省教学成果二等奖1项。荣获欧洲临床药理与治疗学协会青年研究员奖，欧洲围产期与儿科药理协会青年研究员奖、中国研究型医院学会研究型人才等荣誉称号。